Form 8-K - Current report:
SEC Accession No. 0001437749-23-004182
Filing Date
2023-02-22
Accepted
2023-02-22 17:00:28
Documents
15
Period of Report
2023-02-16
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20230220_8k.htm   iXBRL 8-K 26965
2 EXHIBIT 16.1 ex_478934.htm EX-16.1 919
7 a1.jpg GRAPHIC 104289
  Complete submission text file 0001437749-23-004182.txt   304606

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20230216.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20230216_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20230216_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20230216_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20230220_8k_htm.xml XML 2575
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 23654314
SIC: 2836 Biological Products, (No Diagnostic Substances)